Back
Avalo Therapeutics, Inc. Stock Predictions
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
45
AVTX
Avalo Therapeutics, Inc.
Last Price:
$18.57
Seasonality Move:
6.44%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAvalo Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Avalo Therapeutics, Inc. has on average historically fallen by 7.8% based on the past 10 years of stock performance.
-
Avalo Therapeutics, Inc. has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Avalo Therapeutics, Inc. Stock Undervalued?The current Avalo Therapeutics, Inc. [AVTX] share price is $18.60. The Score for AVTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
AVTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Avalo Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Avalo Therapeutics, Inc. has on average historically fallen by 7.8% based on the past 10 years of stock performance.
Avalo Therapeutics, Inc. Stock Rating
Sell
45
Avalo Therapeutics, Inc. (AVTX)
is a Sell
Is Avalo Therapeutics, Inc. overpriced?
-
Avalo Therapeutics, Inc. has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Avalo Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
avalotx.com
52-Week Data
52-Week High:
20.72
52-Week Low:
3.39
Prediction Charts
Market Cap:
337.3M
Price in USD:
18.60
Volume:
374.7K
Beta:
1.29
Technical Analysis
SMA50:
16.63
SMA100:
13.22
SMA200:
9.33
52-Wk Change:
104.17%
Stock Predictions
-
Is Avalo Therapeutics, Inc. stock public?Yes, Avalo Therapeutics, Inc. is a publicly traded company.
-
What is the Avalo Therapeutics, Inc. stock quote today?The Avalo Therapeutics, Inc. stock price is 18.60 USD today.
-
How to buy Avalo Therapeutics, Inc. stock online?You can buy Avalo Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-24 | 17.91 | 18.00 | 18.90 | 17.55 |
| Nov-25 | 18.11 | 18.99 | 19.29 | 18.00 |
| Nov-26 | 19.12 | 18.55 | 19.13 | 18.39 |
| Nov-28 | 18.60 | 19.00 | 19.25 | 18.33 |
| Dec-1 | 18.61 | 16.78 | 18.75 | 16.09 |
| Dec-2 | 16.97 | 15.87 | 16.97 | 15.54 |
| Dec-3 | 15.97 | 16.97 | 16.97 | 15.53 |
| Dec-4 | 16.91 | 17.95 | 18.80 | 16.63 |
| Dec-5 | 17.82 | 17.56 | 18.03 | 17.21 |
| Dec-8 | 17.89 | 19.44 | 20.45 | 17.82 |
| Dec-9 | 19.23 | 19.24 | 19.88 | 18.37 |
| Dec-10 | 19.48 | 19.95 | 20.25 | 19.25 |
| Dec-11 | 19.95 | 19.51 | 20.72 | 19.51 |
| Dec-12 | 19.00 | 18.60 | 19.39 | 18.03 |
Avalo Therapeutics, Inc. Earnings
Avalo Therapeutics, Inc. Earnings Report: Per Share Avalo Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Avalo Therapeutics, Inc. Forecast Revenue Growth
Avalo Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Avalo Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $19.72 per share, and an increase next year of $2.02 per share.
* Avalo Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.